Prio Wealth Limited Partnership Novo Nordisk A S Transaction History

Prio Wealth Limited Partnership

$3.38 Billion
Q3 2024

A detailed history of Prio Wealth Limited Partnership transactions in Novo Nordisk A S stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 199,113 shares of NVO stock, worth $21.1 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

199,113

Previous 201,898 1.38%

Holding current value

$21.1 Million

Previous $28.8 Million 17.73%

% of portfolio

0.7%

Previous 0.87%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$119.07 - $145.42 $331,609 - $404,994	-2,785 Reduced 1.38%	199,113 $23.7 Million
Q2 2024 Sep 10, 2024	BUY	$122.71 - $146.91 $758,470 - $908,050	6,181 Added 3.16%	201,898 $28.8 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $9.91 Million - $13.2 Million	97,069 Added 98.4%	195,717 $25.1 Million
Q4 2023 Jan 22, 2024	BUY	$87.78 - $105.45 $5.34 Million - $6.41 Million	60,832 Added 160.86%	98,648 $10.2 Million
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $1.68 Million - $3.68 Million	18,458 Added 95.35%	37,816 $3.44 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $9,263 - $11,139	-70 Reduced 0.36%	19,358 $3.08 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $29,329 - $38,704	-286 Reduced 1.45%	19,428 $0
Q2 2022 Feb 27, 2023	BUY	$103.24 - $121.81 $32,830 - $38,735	318 Added 1.64%	19,746 $2.2 Million
Q1 2022 Feb 21, 2023	BUY	$93.1 - $112.54 $29,605 - $35,787	318 Added 1.64%	19,746 $2.19 Million
Q4 2021 Feb 17, 2022	SELL	$95.88 - $117.08 $28,859 - $35,241	-301 Reduced 1.5%	19,714 $2.21 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $445,879 - $558,568	-6,590 Reduced 24.77%	20,015 $1.68 Million
Q1 2021 May 06, 2021	SELL	$67.06 - $75.82 $1.17 Million - $1.33 Million	-17,520 Reduced 39.71%	26,605 $1.79 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $11,128 - $14,575	-225 Reduced 0.51%	44,125 $2.66 Million
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $142,620 - $160,290	-3,000 Reduced 6.34%	44,350 $2.29 Million
Q4 2018 Feb 06, 2019	SELL	$41.54 - $47.25 $62,310 - $70,875	-1,500 Reduced 3.07%	47,350 $2.18 Million
Q1 2018 Apr 17, 2018	BUY	$48.49 - $58.14 $2.37 Million - $2.84 Million	48,850 New	48,850 $2.41 Million

Others Institutions Holding NVO

# of Institutions

1,955

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $240B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Account

Prio Wealth Limited Partnership Novo Nordisk A S Transaction History